Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Journal of Hypertension|December 15, 2010
Mutation in the beta adducin subunit causes tissue-specific damage to myogenic toneKazuhiko Sonoyama, Adam S Greenstein, Rosella Micheletti, et al.Cardiovascular Research|May 22, 2007
Role of rat alpha adducin in angiogenesis: null effect of the F316Y polymorphismClaudia Cappuzzello, Roberta Melchionna, Antonella Mangoni, et al.Advances in Experimental Medicine and Biology|December 11, 2012
Cross talk between plasma membrane Na(+)/Ca (2+) exchanger-1 and TRPC/Orai-containing channels: key players in arterial hypertensionMaria V Pulina, A Zulian, Sergey G Baryshnikov, et al.American Journal of Physiology. Renal Physiology|June 6, 2008
alpha-Adducin mutations increase Na/K pump activity in renal cells by affecting constitutive endocytosis: implications for tubular Na reabsorptionLucia Torielli, Simona Tivodar, Rosa Chiara Montella, et al.The Journal of Pharmacology and Experimental Therapeutics|September 24, 2022
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac FunctionMartina Arici, Mara Ferrandi, Paolo Barassi, et al.Journal of Translational Medicine|January 19, 2024
Selective SERCA2a activator as a candidate for chronic heart failure therapyMartina Arici, Shih-Che Hsu, Mara Ferrandi, et al.Bioorganic & Medicinal Chemistry|May 25, 2010
Novel analogues of Istaroxime, a potent inhibitor of Na(+),K(+)-ATPase: Synthesis, structure-activity relationship and 3D-quantitative structure-activity relationship of derivatives at position 6 on the androstane scaffoldMauro Gobbini, Silvia Armaroli, Leonardo Banfi, et al.Journal of Medicinal Chemistry|August 9, 2003
Structure-based design and synthesis of novel potent Na+,K+ -ATPase inhibitors derived from a 5alpha,14alpha-androstane scaffold as positive inotropic compoundsSergio De Munari, Alberto Cerri, Mauro Gobbini, et al.Journal of Medicinal Chemistry|May 17, 2022
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart FailureAndrea Luraghi, Mara Ferrandi, Paolo Barassi, et al.American Journal of Physiology. Renal Physiology|May 16, 2008
Upregulation of apical sodium-chloride cotransporter and basolateral chloride channels is responsible for the maintenance of salt-sensitive hypertensionGiovambattista Capasso, Maria Rizzo, Maria Lisa Garavaglia, et al.Pageof 5